Company’s financing round collecting new funds and talent is now successfully closed. First project together with Tekes fully reached its targets and we just got decision from Business Finland that they will also participate to our R&D phase. This enables solid financial foundation for next 12 months giving us freedom to focus on next steps:
The algorithm development team at Heart2Save just got stronger! We welcome MSc Pekka Kuoppa into the team, which now consists of the following top experts in cardiovascular signal processing: PhD Mika Tarvainen, 15 years of experience in medical signal analysis and physiological modelling PhD Jukka Lipponen, expert in ECG signal analysis and algorithm development MSc
Heart2Save moves into busy R&D phase with a new, strong board: Roope Sihvola Mikko Jalkanen Jussi Holopainen Pia Erkinheimo Mikko Dahlman
When is the right time for a start-up to start sponsoring an athlete? Strong positive cash flow/market position? We desided NOW, in the middle of product developement. Heart2Save proudly support, follow and secure the route of Finnish rower Joel Naukkarinen
Combined Annual Meeting of the Finnish Society for Medical Physics and Medical Engineering and BIOMEP doctoral programme 8-9.2.2019 in Tahko Golden resort. The head of our algorithms PhD Mika Tarvainen gives a presentation. “Physiological monitoring – from research to business”. Come and enjoy. Labquality Days – International Congress on Quality in Laboratory Medicine is one
Preparations for the first clinical evaluations have started and several new frame agreements are under negotiations. Please contact us if you are interested to participate. Company’s financing round collected new investors completing the team with new talent and enabling solid financial foundation for next steps. Financial round is open until 31.12.2017. Please contact if you
Atrial fibrillation detection algorithm provided excellent results and proved to be ready for the medical validation and licensing process. Results were based on the ECG data collected from more than 4000 patients.
Basic research of arrhythmia completed and ready for the first tests with real patient data. Heart2Save won Tahko Ski Lift Pitching competition! See more information from article in Savon Sanomat.
Patent pending for arrhythmia detection EPO.
Company’s pre-seed financing round closed. It was offered for medical experts who are able to support scientific research work around arrhythmia. Patent grounded for cardiac arrest detection with mobile phone.
